| Publications |
- Ho
AY, Atencio DP, Peters S, Stock RG, Formenti SC, Cesaretti JA,
Green S, Haffty B, Drumea K, Leitzin L, Kuten
A, Azria D, Ozsahin M, Overgaard J, Andreassen CN, Trop CS, Park
J, Rosenstein BS. Genetic predictors of adverse radiotherapy effects:
the Gene-PARE project. Int J Radiat Oncol Biol Phys. 2006 Jul
1;65(3):646-55.
-
Lally BE, Zelterman D, Colasanto JM, Haffty BG,
Detterbeck FC, Wilson LD. Postoperative radiotherapy for stage
II or III non-small-cell lung cancer using the surveillance, epidemiology,
and end results database. J Clin Oncol. 2006 Jul 1;24(19):2998-3006.
Epub 2006 Jun 12.
- Jeruss
JS, Vicini FA, Beitsch PD, Haffty BG, Quiet
CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA,
Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM. Initial
outcomes for patients treated on the American Society of Breast
Surgeons MammoSite clinical trial for ductal carcinoma-in-situ
of the breast. Ann Surg Oncol. 2006 Jul;13(7):967-76. Epub 2006
May 16.
- Pierce
LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ,
Harris EE, Gaffney DK, Haffty BG, Dawson LA,
Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, Isaacs
C, Merajver SD, Wong JS, Garber JE, Weber BL. Ten-year multi-institutional
results of breast-conserving surgery and radiotherapy in BRCA1/2-associated
stage I/II breast cancer. J Clin Oncol. 2006 Jun 1;24(16):2437-43.
Epub 2006 Apr 24.
- Choi
DH, Lee MH, Haffty BG. Double heterozygotes
for non-Caucasian families with mutations in BRCA-1 and BRCA-2
genes. Breast J. 2006 May-Jun;12(3):216-20.
- Kwong
MS, Chung GG, Horvath LJ, Ward BA, Hsu AD, Carter D, Tavassoli
F, Haffty B, Burtness BA. Postchemotherapy MRI
overestimates residual disease compared with histopathology in
responders to neoadjuvant therapy for locally advanced breast
cancer. Cancer J. 2006 May-Jun;12(3):212-21.
- Haffty
BG, Kim JH, Yang Q, Higgins SA. Concurrent chemo-radiation
in the conservative management of breast cancer. Int J Radiat
Oncol Biol Phys. 2006 May 31; [Epub ahead of print].
- Smith
GL, Smith BD, Haffty BG. Rationalization and
regionalization of treatment for ductal carcinoma in situ of the
breast. Int J Radiat Oncol Biol Phys. 2006 May 31; [Epub ahead
of print]
- Smith
BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty
BG. Effectiveness of radiation therapy for older women
with early breast cancer. J Natl Cancer Inst. 2006 May 17;98(10):681-90.
- Jeruss
JS, Vicini FA, Beitsch PD, Haffty BG, Quiet
CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA,
Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM. Initial
Outcomes for Patients Treated on the American Society of Breast
Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ
of the Breast. Ann Surg Oncol. 2006 May 16; [Epub ahead of print].
- Kim
JH, Tavassoli F, Haffty BG. Chest wall relapse
after mastectomy for ductal carcinoma in situ: a report of 10
cases with a review of the literature. Cancer J. 2006 Mar-Apr;12(2):92-101.
- Haffty
BG, Silber A, Matloff E, Chung J, Lannin D. Racial differences
in the incidence of BRCA1 and BRCA2 mutations in cohort of early
onset breast cancer patients: African American compared to White
Women. J Med Genet. 2006 Feb;43(2):133-7. Epub 2005 Jun 27.
- Weinberger
PM, Yu Z, Haffty BG, Kowalski D, Harigopal M,
Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A. Molecular
Classification Identifies a Subset of Human Papillomavirus-Associated
Oropharyngeal Cancers With Favorable Prognosis. J Clin Oncol.
2006 Feb 10;24(5):736-47.
- Abu-Khalaf
MM, Windsor S, Ebisu K, Salikooti S, Ananthanarayanan G, Chung
GG, DiGiovanna MP, Haffty BG, Abrams M, Farber
LR, Hsu AD, Reiss M, Zelterman D, Burtness BA. Five-year update
of an expanded phase II study of dose-dense and -intense doxorubicin,
paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.
Oncology. 2005;69(5):372-83. Epub 2005 Nov 24.
- Alpert
TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG.
Ipsilateral breast tumor recurrence after breast conservation
therapy: Outcomes of salvage mastectomy vs. salvage breast-conserving
surgery and prognostic factors for salvage breast preservation.
Int J Radiat Oncol Biol Phys. 2005 Nov 1;6(3):845-51.
- Higgins
SA, Matloff ET, Rimm DL, Dziura J, Haffty BG,
King BL. Patterns of reduced nipple aspirate fluid production
and ductal lavage cellularity in women at high risk for breast
cancer. Breast Cancer Res. 2005;7(6):R1017-22. (Epub 2005 Oct
24).
- Zannis
V, Beitsch P, Vicini F, Quiet C, Keleher A, Garcia D, Snider H,
Gittleman M, Kuerer H, Whitacre E, Whitworth P, Fine R, Haffty
BG, Stolier A, Mabie J. Descriptions and outcomes of
insertion techniques of a breast brachytherapy balloon catheter
in 1403 patients enrolled in the American Society of Breast Surgeons
MammoSite breast brachytherapy registry trial. Am J Surg, 2005
Oct;190(4):530-8.
- Choi
DH, Kim S, Rimm DL, Carter D, Haffty BG. Immunohistochemical
biomarkers in patients with early-onset breast carcinoma by tissue
microarray. Cancer J. 2005 Sep-Oct;11(5):404-11.
- Moran
MS, Colasanto JM, Haffty BG, Wilson LD, Lund
MW, Higgins SA. Effects of breast-conserving therapy on lactation
after pregnancy. Cancer J. 2005 Sep-Oct;11(5):399-403.
- Psyrri
A, Yu Z, Weinberger PM, Sasaki C, Haffty BG,
Camp R. Quantitative determination of nuclear and cytoplasmic
epidermal growth factor receptor expression in oropharyngeal squamous
cell cancer by using automated quantitative analysis. Clin Cancer
Res. 2005 Aug 15;11(16):5856-62.
|
Print this page